2020台灣生技月 Bio Taiwan 生物科技大展

2020 台灣生技月 南港展覽館

講師

Vera Salus Ricerca (VSR)

Company Presentations

Friday, July 24 Company Presentations 7–Italy

Vera Salus Ricerca (VSR)

Company Info

Name /Vera Salus Ricerca (VSR)

Address /Via A. Broggi 10, 96100 Siracusa (Italy)

Website /www.verasalusricerca.it/en/home-page-2/

Presenter

Name /Paolo Correale

Title /Founder

Email /paolo.correale@verasalusricerca.it

Telephone /(Work) +39 340 3329371

Fax /

Mobile /+39 340 3329371

Company Type

Biotechnology,Pharmaceutical

About the Company

Vera Salus Ricerca (VSR) is an innovative biopharma company whose core capability is the discovery of best-in-class drug candidates originated from natural compounds.

Research is led by Prof. Giovanni Pitari from T. Jefferson University of Philadelphia, in collaboration with the Italian National Council for Research (CNR).

R&D team brings a unique blend of capabilities: deep understanding of Clinical and Translational Pharmacology, world-class expertise in Drug Modelling and Medicinal Chemistry, extensive knowledge of Molecular Biology and Genetics.

Brief Description of main products or services

Over billions of years, the slow march of life has brought about natural agents gradually selected for their ability to modulate biological processes; but evolution's products do not often show traits required for medicinal use.

Relying on the evolutionary process that shaped natural chemicals, we continuously run a “nature screening engine” fed by libraries of natural extracts and compounds to identify strands of distinct biological activity.

Promising natural compounds are broken down to their active parts, molecularly and iteratively re-engineered through green lego-chemistry guided by sophisticated SAR studies, and transformed into novel, safe drugs.

VSR’s key results consist in New Chemical Entities with improved efficacy, druglikeness & patentability.

Proprietary drug platform technologies, suitable for co-development partnership and investment:

  • Target therapies for mutant RAS solid cancers
  • Senolytic drugs

Contract research services:

  • Targeted medicinal chemistry improvement of efficacy, druglikeness and patentability of drug candidates, including natural compounds
  • Screening of our natural extracts library to identify biologically active natural compounds suitable for specific pathologies/conditions
  • Third party natural extracts analysis: targeted metabolic fingerprinting, HPLC/DAD/ELSD/MS-based identification and quantification, biological activity assessment of principal components
  • Specific preclinical research services (including animal studies)

Contact Person

Name /Paolo Correale

Email /paolo.correale@verasalusricerca.it

Phone /(Work) +39 340 3329371